Adient plc

ADNT
Financial Analysis · Updated June 3, 2026 · Coverage 2026-Q2

Business Overview


source: coverage-next-full step: 01 ticker: ADNT company: Adient plc date: 2026-06-03

Step 01 — Business Model & Overview: ADNT (Adient plc)

1. Business Description

Adient plc is the world's largest pure-play automotive seating supplier. The company provides complete seating systems — from raw foam and fabric through finished, fully-assembled seat sets — to virtually every major OEM on the planet. Founded through a 2016 spinoff from Johnson Controls International, Adient now serves as the global #1 or #2 supplier of seating to light vehicle OEMs in each major geography. [S1]

Core product scope:

  • Complete seat systems (front and rear; bench, bucket, and split configurations)
  • Seat structures and mechanisms (recliner systems, slides, height adjusters)
  • Foam and trim components
  • Head restraints, armrests, and seat covers
  • Seating for commercial vehicles and specialty applications

What Adient does NOT do:

  • Electronics integration in seats (heated/ventilated elements sourced externally) — contrast Lear's E-Systems segment
  • Overhead systems, instrument panels, or door panels
  • Vehicle exteriors or powertrain components

2. Value-Chain Layer Map

Raw Materials → Tier 2 Suppliers → Adient (Tier 1) → OEM Assembly → Consumer

Upstream dependencies:

  • Steel (seat structures/mechanisms) — primary input cost; ~30-35% of COGS
  • Foam chemicals (MDI/polyols) — petrochemical-linked pricing
  • Fabric and leather — sourced regionally; SX Beteiligungen GmbH (Germany-based foam/cover operation)
  • Electronic components for adjusters — exposed to semiconductor availability

Adient's position (Tier 1):

  • Receives OEM purchase orders typically 3-7 years in duration (program lifecycle)
  • "Seat-in" basis: delivers assembled seats to OEM production lines on just-in-time (JIT) schedule
  • Pricing set at program outset with limited pass-through; periodic renegotiation for steel/resin escalators
  • Manufacturing co-located near or adjacent to OEM plants (sequencing centers)

Downstream (OEM customers):

  • Stellantis (largest customer historically ~20%+ of revenue)
  • Ford Motor Company (~13%)
  • GM (~10%)
  • Toyota (~8%)
  • BMW/Mercedes/VW Group
  • Chinese OEMs (via YFAS JV): SAIC, BAIC, BYD, and emerging C-OEMs

End demand: Global light vehicle production (~90-95M units/year in FY2025 context; IHS/S&P Global estimates)

3. Segment Architecture [S1][S2]

Americas
  • Revenue (FY2025): ~$6.8B | Adj. EBITDA margin: ~6.6%
  • Geography: US, Canada, Mexico
  • Customers: Stellantis NA, Ford, GM, Toyota NA
  • Competitive position: #1 in US full-size truck and SUV seating
  • Plants: ~30 manufacturing/sequencing facilities in North America
EMEA (Europe, Middle East, Africa)
  • Revenue (FY2025): ~$5.5B | Adj. EBITDA margin: ~2.6%
  • Geography: Germany (largest), Czech Republic, Poland, UK, Russia (exit), Morocco, Turkey
  • Customers: BMW, Mercedes, VW/Audi, Stellantis Europe, Renault/Nissan
  • Structural challenge: European light vehicle production has declined structurally; legacy footprint too large; EMEA adj. EBITDA margin collapsed from 4.8% (FY2022) to 2.6% (FY2025). Active $120-130M restructuring underway to right-size cost base. [S2]
  • KEIPER (metallic components JV) presents ongoing earnings drag post-JV restructuring
Asia
  • Revenue (FY2025, equity share): ~$2.2B | Adj. EBITDA margin: ~13.2%
  • Geography: China (dominant via YFAS JV), Japan, South Korea, India, Thailand
  • Structure: Adient's Asia business includes its proportionate share of Yanfeng Adient Seating Co. (YFAS), the #1 seating supplier in China by volume
  • C-OEM acceleration: $1.1B in new business wins with Chinese domestic OEMs (BYD, AITO/Huawei, others) announced in FY2025; 18% H1 FY2026 revenue growth in Asia
  • New Zhangjiakou JV opened for NEV-adjacent programs

4. Revenue Model

How Adient earns money:

  1. Per-seat revenue — priced per program at sourcing; includes amortization of tooling costs. Margins are thin by design; value is in volume and program wins.
  2. Components/kits — seat structures, foam, trim sold separately to customers that self-assemble (less common; primarily EMEA)
  3. Equity income — from YFAS and other Asia JVs; flows through "Asia" segment. Cash received as dividends from JVs.
  4. Cost pass-through mechanisms — limited; steel surcharge mechanisms exist in some contracts but coverage is incomplete

Pricing power: LOW at the contract level. Pricing set at RFQ/program award; OEMs pressure for annual productivity givebacks (~1-3%/year on average in the industry). Adient's competitive position protects volume but not margin expansion.

5. Business Model Economics

Metric FY2025 Peer Benchmark (LEA seating)
Revenue $14.5B ~$17.2B (Lear seating)
Adj. EBITDA Margin 6.1% ~6.5%
FCF / Adj. EBITDA ~23% ~25%
CapEx / Revenue ~1.9% ~2.1%
Net Debt / Adj. EBITDA ~2.0x ~1.0x

Adient runs a sub-par capital structure vs. Lear, which limits financial flexibility. The Asia business with 13%+ margins is the crown jewel; the EMEA drag is the primary earnings lever.

6. Key Business Risks at the Overview Level

  • Customer concentration: Top 3 customers (Stellantis, Ford, GM) likely represent 40-45% of revenue. Loss of a major program would be structurally damaging.
  • LVP correlation: Revenue highly correlated to global light vehicle production; 1% LVP change ≈ ~0.8-1% Adient revenue change.
  • EMEA structural decline: European OEM volume under pressure from Chinese imports; Adient's European plants have high fixed-cost structure.
  • JV dependency: Asia profits flow through JVs; YFAS governance involves Yanfeng as co-partner; Adient has limited unilateral control.
  • Tariff exposure: US tariffs on auto imports/parts disrupt OEM production scheduling which flows to Adient's sequencing economics.

Source Index

ID Source Description
S1 SEC 10-K FY2025 (CIK 1670541) Annual report FYE September 30, 2025; segments, customers, products
S2 ADNT_financials/other/stockanalysis_summary.md Segment financials, market data; StockAnalysis 2026-06-03
S3 ADNT_financials/industry/market_overview.md Global automotive seating market; Tavily 2026-06-03
S4 ADNT_financials/other/consensus.md FY2026 guidance, recent results; Tavily 2026-06-03

Financial Snapshot


source: coverage-next-full step: 04 ticker: ADNT company: Adient plc date: 2026-06-03

Step 04 — Financial Quality & Adversarial Sweep: ADNT (Adient plc)

1. Income Statement Quality

Revenue Recognition

Adient recognizes revenue consistent with ASC 606 on a per-unit / per-program basis as seats are delivered to OEM assembly lines. Revenue is point-in-time (delivery), not over-time. Quality: HIGH — no concern with timing manipulation; physical delivery is verifiable. [S1]

Adjusted EBITDA vs. GAAP

Adient's management-defined "Adj. EBITDA" is the primary reported profitability metric. Key adjustments include:

Adjustment FY2025 FY2024 Nature
Restructuring / exceptional ~$180M ~$159M Cash, recurring in nature
Goodwill impairment ~$333M ~$0M Non-cash, EMEA segment
KEIPER impairment/losses ~$30M ~$60M JV-related non-cash
Equity income adj. Various Various JV attribution

FLAG: The restructuring charges (~$159-180M in both FY2024 and FY2025) are recurring, suggesting ADNT's adj. EBITDA consistently overstates sustainable earnings power. True "recurring" FCF must deduct a normalized restructuring run-rate of ~$50-100M. Goodwill impairment is properly excluded from adj. EBITDA. [S1]

Revenue vs. Adj. EBITDA Trend
FY Revenue Adj. EBITDA Adj. EBITDA%
FY2021 $14.0B ~$725M 5.2%
FY2022 $14.6B ~$810M 5.5%
FY2023 $14.5B ~$845M 5.8%
FY2024 $14.7B ~$862M 5.9%
FY2025 $14.5B ~$881M 6.1%

Gradual margin improvement despite revenue stagnation — driven by EMEA footprint actions and Americas operational improvements. Quality: MODERATE — trend is real but heavily depends on adj. EBITDA definition. [S1][S2]

2. Balance Sheet Quality

Goodwill & Intangibles
Item Value (FQ2 FY2026) Concern Level
Goodwill ~$900M (post FY2025 impairment of $333M) MEDIUM — EMEA impairment risk remains
Other intangibles ~$250M Low

FY2025 included a $333M EMEA goodwill impairment — this is important because it signals management (and auditors) formally acknowledged EMEA's structural deterioration. Remaining goodwill is tilted toward Americas (healthier) and prior acquisition premiums. [S1]

Residual EMEA goodwill impairment risk exists but the large FY2025 write-down significantly reduced the risk of a repeat.

Working Capital

Adient is a JIT supplier with negative-to-neutral working capital dynamics:

  • Receivables: typically 30-45 days; collected promptly from creditworthy OEMs
  • Inventory: minimal (JIT manufacturing means low inventory buffer)
  • Payables: 60-90 days to sub-tier suppliers
  • Result: Working capital is NOT a significant cash drain; this is a positive quality attribute.
Debt Structure [S1][S3]
Instrument Balance (est.) Rate Maturity
Term Loan B ~$625M SOFR+175bps (~7.2%) 2031
Senior Secured Notes ~$500M 7.00% 2028
Senior Unsecured Notes ~$500M 7.50% 2030
Unsecured Notes (legacy) ~$400M 4.875% 2026 (refinanced)
ABL Revolver $0 drawn SOFR+125bps 2028
Total Gross Debt ~$2.4B
Cash ~$800M
Net Debt ~$1.6-1.8B

Feb 2025 refinancing extended 2026 maturity. However, the new debt carries materially higher coupon (4.875% → 7.50%), creating a significant annual interest cost increase (~$30-40M/year incremental). Net Debt/Adj. EBITDA ~2.0x — manageable but leaves limited room for downward EBITDA revision. [S1][S3]

Pension & Employee Obligations
  • Defined benefit pension plans primarily in EMEA (Germany, UK)
  • Estimated underfunded pension liability: ~$200-400M (underfunded EMEA plans)
  • Cash funding requirements ~$30-50M/year
  • FLAG: This is an underappreciated liability that reduces true enterprise value. Must be added to net debt in valuation. [S1]

3. Cash Flow Quality

FY OCF CapEx FCF (S&U def) FCF Mgmt def
FY2021 $394M $(284M) $110M N/A
FY2022 $374M $(313M) $61M ~$40M
FY2023 $464M $(299M) $165M ~$150M
FY2024 $472M $(266M) $206M ~$180M
FY2025 $546M $(274M) $272M ~$204M

FCF has improved steadily from post-COVID trough. CapEx as a % of revenue is declining slightly (~2.1% → ~1.9%), which may reflect reduced investment in EMEA as restructuring reduces footprint. Quality: MODERATE-HIGH — OCF is real, FCF growing, but management's definition excludes some restructuring cash outflows. [S2]

FY2026 guidance of ~$130M FCF is sharply lower than FY2025's ~$204M due to ~$120-130M restructuring cash payments, not operational deterioration. Normalized post-restructuring FCF should recover to $200-250M+ by FY2027.

4. Earnings Quality Red Flags

Flag Severity Detail
Recurring restructuring charges (adj. out) MEDIUM $159M (FY2024), $180M (FY2025); suggestive of structural, not one-time, nature
EMEA goodwill impairment LOW-MEDIUM $333M write-down taken; residual risk reduced but EMEA remains challenged
JV accounting complexity MEDIUM YFAS equity-method income can obscure true China cash generation; dividends received ≠ income recognized
Interest rate refinancing MEDIUM Feb 2025 refi extended maturity but at ~$30-40M higher annual interest cost
CEO/CFO both new (Jan 2024) LOW New leadership may signal prior management inadequacy; also creates risk of kitchen-sink charges in FY2024-2025
Pension underfunding LOW ~$200-400M underfunded EMEA plans are off-balance-sheet economic liability

5. Adversarial Research Sweep

Short Reports / Investigations

No major published short reports found on ADNT. The stock has been a long-running value trap by many accounts but has not attracted explicit short-seller reports (unlike, e.g., some Chinese auto companies). The thesis against ADNT is predominantly fundamental (EMEA structural decline, leverage) rather than accounting fraud concerns.

Legal / Regulatory Actions [S4]
  • Price-fixing investigations: Adient's predecessor JCI automotive seating business settled with DOJ on auto parts price-fixing (industry-wide investigation that included multiple Tier 1 suppliers) in the 2014-2018 period. As of FY2025 filings, no material ongoing price-fixing liability.
  • EMEA labor disputes: Ongoing restructuring in Germany and Czech Republic has led to works council negotiations; management has disclosed ~$120-130M total charge; no criminal allegations.
  • Environmental: Typical manufacturing liability disclosures; no material ongoing enforcement actions.
  • Derivative suits: None material in recent proxy disclosures.
  • FLAG: No smoking gun. ADNT's risks are operational and strategic, not legal/governance. [S1][S4]
Competitor/Industry Red Flags
  • Industry-wide: automaker warranty claims for seating defects can create recall exposure; Adient has had modest warranty reserve usage but no major recall program
  • YFAS JV: Chinese partner (Yanfeng) has independent interests; JV governance is an inherent risk, though the relationship has been stable since JV restructuring in 2020-2021

6. Statement Adjustments for Valuation

To arrive at a "clean" earnings base for valuation:

Adj. EBITDA (reported) ~$881M
Less: Normalized restructuring (ongoing) ~-$75M
Less: Pension cash funding ~-$40M
Adjusted EBITDA (clean) ~$766M
Add: D&A ~$350M
Less: CapEx ~-$274M
Less: Interest (cash) ~-$175M
Less: Taxes (normalized) ~-$75M
Clean FCF (normalized) ~$592M Adj EBITDA → ~$170-200M FCF

Note: "Normalized" FCF excludes large restructuring payments specific to FY2026 (~$130M guided FCF is depressed by restruc).

Source Index

ID Source Description
S1 SEC 10-K FY2025 (CIK 1670541) Income statement, balance sheet, notes, risk factors
S2 ADNT_financials/other/stockanalysis_summary.md Cash flow, ratios
S3 ADNT_financials/sec_filings/10K_FY2025_summary.md Debt structure detail
S4 ADNT_financials/other/consensus.md + Tavily search Litigation, regulatory context

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $ADNT.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/ADNT/fundamental$1.00 · Bearer token required
Markdown: /stocks/adnt/financials/md · → thesis · → memo